Roswell Park introduces new PanHeme blood cancer test

“US-based Roswell Park Comprehensive Cancer Center has introduced the new advanced, high-speed blood cancer test, PanHeme.  Leveraging next-generation gene sequencing technology, the new test will enable the diagnosis of blood cancers such as multiple myeloma, lymphoma and leukaemia.  The test can accurately detect gene mutations in hundreds of genes within 72 hours, a significant improvement from the current wait time of three to four weeks for molecular testing. Recently, Agilent Technologies obtained a licence for the commercial development of this test.  The PanHeme panel covers all haematological malignancies and every mutation needed for diagnosing, treating and determining the prognosis for these patients.”      MORE

Image Credit:  Medical Device

: